湖南迪诺制药

Hunan Dino Pharmaceutical is a prominent Chinese pharmaceutical enterprise focused on the development, production, and commercialization of high-quality chemical drugs. Established in 1997 and based in the Liuyang Biological Medicine Park in Changsha, the company has built a significant portfolio centered on digestive system treatments, cardiovascular health, and anti-infectives. Its flagship products include proton pump inhibitors such as lansoprazole and rabeprazole, which hold substantial market share in China. The company operates advanced GMP-compliant manufacturing lines for various dosage forms, including tablets, capsules, and injections. Hunan Dino continues to expand its reach through a robust domestic distribution network and ongoing generic drug consistency evaluations.